Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Preparing Protein Antigens from Sodium Dodecyl Sulfate-Polyacrylamide Gels for Immunization.

Greenfield EA, DeCaprio J, Brahmandam M.

Cold Spring Harb Protoc. 2019 Dec 2;2019(12):pdb.prot100008. doi: 10.1101/pdb.prot100008.

PMID:
31792141
2.

Detecting Protein Antigens in Sodium Dodecyl Sulfate-Polyacrylamide Gels.

Greenfield EA, DeCaprio J, Brahmandam M.

Cold Spring Harb Protoc. 2019 Dec 2;2019(12):pdb.prot099994. doi: 10.1101/pdb.prot099994.

PMID:
31792140
3.

Transfected Dendritic Cell Immunizations.

Greenfield EA, DeCaprio J, Brahmandam M.

Cold Spring Harb Protoc. 2019 Mar 1;2019(3). doi: 10.1101/pdb.prot100073.

PMID:
30824623
4.

Preparing Antigens Using a Baculovirus Expression System.

Greenfield EA, DeCaprio J, Brahmandam M.

Cold Spring Harb Protoc. 2018 Dec 3;2018(12). doi: 10.1101/pdb.prot100065.

PMID:
30510129
5.

Making Weak Antigens Strong: Cross-Linking Peptides to KLH with Maleimide.

Greenfield EA, DeCaprio J, Brahmandam M.

Cold Spring Harb Protoc. 2018 Oct 1;2018(10). doi: 10.1101/pdb.prot100016.

PMID:
30275080
6.

Making Weak Antigens Strong: Modifying Protein Antigens by Denaturation.

Greenfield EA, DeCaprio J, Brahmandam M.

Cold Spring Harb Protoc. 2018 May 1;2018(5). doi: 10.1101/pdb.prot099960.

PMID:
29717055
7.

Making Weak Antigens Strong: Modifying Antigens by Dinitrophenol or Arsynyl Coupling.

Greenfield EA, DeCaprio J, Brahmandam M.

Cold Spring Harb Protoc. 2018 May 1;2018(5). doi: 10.1101/pdb.prot099952.

PMID:
29717054
8.

Developing a Phosphospecific IHC Assay as a Predictive Biomarker for Topoisomerase I Inhibitors.

Ando K, Tohme YH, Srinivasiah A, Taylor-Parker J, Harrington Y, Shah AK, Oki E, Brahmandam M, Bharti AK.

J Histochem Cytochem. 2018 Aug;66(8):549-561. doi: 10.1369/0022155418766503. Epub 2018 Mar 27.

9.

Cross-reactivity of the BRAF VE1 antibody with epitopes in axonemal dyneins leads to staining of cilia.

Jones RT, Abedalthagafi MS, Brahmandam M, Greenfield EA, Hoang MP, Louis DN, Hornick JL, Santagata S.

Mod Pathol. 2015 Apr;28(4):596-606. doi: 10.1038/modpathol.2014.150. Epub 2014 Nov 21.

10.

No evidence for interference of h&e staining in DNA testing: usefulness of DNA extraction from H&E-stained archival tissue sections.

Morikawa T, Shima K, Kuchiba A, Yamauchi M, Tanaka N, Imamura Y, Liao X, Qian ZR, Brahmandam M, Longtine JA, Lindeman NI, Fuchs CS, Ogino S.

Am J Clin Pathol. 2012 Jul;138(1):122-9. doi: 10.1309/AJCP28LAOOKSZSVW.

11.

Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target.

Chauhan D, Singh AV, Brahmandam M, Carrasco R, Bandi M, Hideshima T, Bianchi G, Podar K, Tai YT, Mitsiades C, Raje N, Jaye DL, Kumar SK, Richardson P, Munshi N, Anderson KC.

Cancer Cell. 2009 Oct 6;16(4):309-23. doi: 10.1016/j.ccr.2009.08.019.

12.

Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma.

Chauhan D, Singh A, Brahmandam M, Podar K, Hideshima T, Richardson P, Munshi N, Palladino MA, Anderson KC.

Blood. 2008 Feb 1;111(3):1654-64. Epub 2007 Nov 15.

13.

A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma.

Chauhan D, Velankar M, Brahmandam M, Hideshima T, Podar K, Richardson P, Schlossman R, Ghobrial I, Raje N, Munshi N, Anderson KC.

Oncogene. 2007 Apr 5;26(16):2374-80. Epub 2006 Oct 2.

PMID:
17016430
14.

Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma.

Ogino S, Odze RD, Kawasaki T, Brahmandam M, Kirkner GJ, Laird PW, Loda M, Fuchs CS.

Am J Surg Pathol. 2006 Sep;30(9):1175-83.

PMID:
16931963
16.

Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis.

Ogino S, Brahmandam M, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS.

Mod Pathol. 2006 Aug;19(8):1083-90. Epub 2006 May 12.

17.

Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis.

Ogino S, Kawasaki T, Brahmandam M, Cantor M, Kirkner GJ, Spiegelman D, Makrigiorgos GM, Weisenberger DJ, Laird PW, Loda M, Fuchs CS.

J Mol Diagn. 2006 May;8(2):209-17.

18.

CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies.

Ogino S, Cantor M, Kawasaki T, Brahmandam M, Kirkner GJ, Weisenberger DJ, Campan M, Laird PW, Loda M, Fuchs CS.

Gut. 2006 Jul;55(7):1000-6. Epub 2006 Jan 11.

19.

Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer.

Ogino S, Meyerhardt JA, Cantor M, Brahmandam M, Clark JW, Namgyal C, Kawasaki T, Kinsella K, Michelini AL, Enzinger PC, Kulke MH, Ryan DP, Loda M, Fuchs CS.

Clin Cancer Res. 2005 Sep 15;11(18):6650-6.

20.

Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component.

Ogino S, Brahmandam M, Cantor M, Namgyal C, Kawasaki T, Kirkner G, Meyerhardt JA, Loda M, Fuchs CS.

Mod Pathol. 2006 Jan;19(1):59-68.

21.

Sensitive sequencing method for KRAS mutation detection by Pyrosequencing.

Ogino S, Kawasaki T, Brahmandam M, Yan L, Cantor M, Namgyal C, Mino-Kenudson M, Lauwers GY, Loda M, Fuchs CS.

J Mol Diagn. 2005 Aug;7(3):413-21.

Supplemental Content

Loading ...
Support Center